About 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole
2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole (PubChem CID 141086714) has the molecular formula C32H24N14S
and a molecular weight of 636.71 g/mol. Its IUPAC name is 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole.
Molecular Properties
| Compound Name | 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole |
| PubChem CID | 141086714 |
| Molecular Formula | C32H24N14S |
| Molecular Weight | 636.71 g/mol |
| Exact Mass | 636.20 |
| IUPAC Name | 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole |
| SMILES | c1cnc(C2(c3cc4ccccc4[nH]3)N(c3cnccn3)N(c3cccnn3)N(c3ccc[nH]3)C2(c2ncc[nH]2)c2nccs2)nc1 |
| InChI | InChI=1S/C32H24N14S/c1-2-7-23-22(6-1)20-24(42-23)31(28-36-11-5-12-37-28)32(29-38-16-17-39-29,30-40-18-19-47-30)44(25-8-3-10-34-25)46(26-9-4-13-41-43-26)45(31)27-21-33-14-15-35-27/h1-21,34,42H,(H,38,39) |
| InChIKey | ILRVEHNQWWRVKQ-UHFFFAOYSA-N |
| XLogP | 4.60 |
| TPSA | 160.21 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 636.71 |
| LogP ≤ 5 | 4.60 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Analyze 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole?
The IUPAC name of 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole (CID 141086714) is 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole.
What is the SMILES notation for 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole?
The canonical SMILES for 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole is c1cnc(C2(c3cc4ccccc4[nH]3)N(c3cnccn3)N(c3cccnn3)N(c3ccc[nH]3)C2(c2ncc[nH]2)c2nccs2)nc1.
What is the InChIKey of 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole?
The InChIKey is ILRVEHNQWWRVKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H24N14S/c1-2-7-23-22(6-1)20-24(42-23)31(28-36-11-5-12-37-28)32(29-38-16-17-39-29,30-40-18-19-47-30)44(25-8-3-10-34-25)46(26-9-4-13-41-43-26)45(31)27-21-33-14-15-35-27/h1-21,34,42H,(H,38,39).
What are the key properties of 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole?
2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole has a molecular weight of 636.71 g/mol, XLogP of 4.60, 7 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(1H-imidazol-2-yl)-5-(1H-indol-2-yl)-1-pyrazin-2-yl-2-pyridazin-3-yl-5-pyrimidin-2-yl-3-(1H-pyrrol-2-yl)triazolidin-4-yl]-1,3-thiazole is sourced from PubChem (CID 141086714), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).